A, B and C arms) such as ABC, ACB, BAC, BCA, CAB, or CBA
Injectable routes carry a particular concern for immunogenicity from peptide aggregation and impurities, and FDA noted the available certificates of analysis for AOD-9604 bulk drug substances did not consistently control for impurities, aggregates, or microbial limits
If youre in a regulated field, we recommend discussing this with your provider our clinical team at THE RE/ CLINIC can help guide you
And if youre needle-averse, Infiniwell removes the injection barrier completely
And so I feel that if I can train more practitioners to do this work, then then it's, it's a win-win for everyone, right, because then the patients have more options for, for treatment
A glutathione injection sidesteps that entirely, delivering the molecule into the bloodstream directly and making bioavailability a much smaller variable in the equation